Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2022.03.31
2021年度业绩快报
2022.03.30
Date of Board Meeting
2022.03.30
(1) DELAY IN PUBLICATION OF AUDITED ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR END...
2022.03.28
关于2021年年度报告预约披露时间变更的公告
2022.03.25
关于向专业投资者公开发行公司债券注册获中国证监会批复的公告
2022.03.18
H股公告
2022.03.18
DATE OF BOARD MEETING
2022.03.15
“HEPARIN SODIUM ACTIVE PHARMACEUTICAL INGREDIENT AND ENOXAPARIN SODIUM ACTIVE PH...
2022.03.15
肝素鈉原料藥及依諾肝素鈉原料藥獲印度批准
2022.03.02
Monthly Return 月報表
第一页
上一页
33
34
35
36
37
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
